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Traditional Chinese medicine suggests that renal deﬁciency is a causative factor of asthma, and tonifying kidney drugs are believed
to be an appropriate and beneﬁcial treatment. The adrenal medullary chromaﬃn cells (AMCC) transition to the neuronal
phenotype is known to occur in asthma, as evidenced by degranulation of chromaﬃn granules, decline of epinephrine (EPI)
and phenylethanolamine-n-methyl transferase (PNMT), and obvious alterations in cellular architecture. In this study, rats were
sensitized and challenged with ovalbumin, then treated with Kidney-Tonifying Recipe (KTR) to evaluate the therapeutic eﬀect.
TissueswereevaluatedforchangesinpathologyandEPI,PNMT,andperipherinexpression.Degranulationofchromaﬃngranules
and appearance of neurite-like process were found in AMCC from asthmatic rats, and these changes were corrected by KTR
treatment. EPI and PNMT expressions were decreased in asthmatic rats and increased by KTR treatment. Peripherin expression
was increased in asthmatic rats and decreased in the KTR-treated group. Morphological changes and decreases in EPI were
observed when cultured AMCC were exposed to sera from asthmatic rats in vitro, and these changes were attenuated with the
addition of sera from KRT-treated rats. These results suggest that the Kidney-Tonifying Recipe is capable of repairing asthma-
associated alterations in endocrine function and the ultrastructure of AMCC.
1.Introduction
Traditional Chinese medicine (TCM) considers renal deﬁ-
ciency as a principal cause of asthma. A toniﬁcation strategy
for kidney is often used to treat asthma in TCM, and many
consider this to be a highly eﬀective therapeutic approach
[1, 2]. Recent studies into renal deﬁciency have implicated
an imbalance of the neuroendocrine system as an underlying
cause [3–5].
Asthma attacks are induced by the dysfunction of cholin-
ergic and adrenergic nerves and their cognate receptors.
Since there is a lack of adrenergic nerves innervating the
human airway smooth muscles, the relaxation of airways is
mainly regulated by epinephrine (EPI) binding to adrenergic
receptors. Adrenal medullary chromaﬃn cells (AMCC) are
the primary cells that secrete EPI [6, 7], and are thus impor-
tant elements of the neuroendocrine system. Asthmatic
patients have been shown to have signiﬁcantly decreased
levels of endogenous EPI, suggesting that EPI release could
be impaired in this disease process [8, 9]. Previous work by
our group has demonstrated that EPI levels are decreased in
asthmatic rats, as compared with control rats, and that this
decrease may, at least partially, be mediated by a phenotype
transition from AMCCs to neurons [10–12].
The role and mechanisms underlying the beneﬁcial
eﬀects that are observed upon use of tonifying kidney drugs
are unclear. We hypothesized that tonifying kidney drugs
aﬀect the structure and function of AMCC. In this study,
asthmatic rats were treated with a classic TCM formula
known as Kidney-Tonifying Recipe (KTR), and the eﬀects of
the kidney-tonifying drugs on the alteration of structure and
function of AMCC in asthma were investigated.
2.MaterialsandMethods
2.1. The Kidney-Tonifying Recipe. K T Ri sc o m p o s e do fReh-
mannia glutinosa (Shudi), oriental water plantain rhizome
(Zexie), monkshood (Fupian), medicinal Indian mulberry2 Evidence-Based Complementary and Alternative Medicine
root (Bajitian), Common Yam Rhizome (Huaishan), Indian
Buead (Fuling), cortex cinnamomi (Rougui), salvia chinensis
(Danpi), cistanche (Roucongrong), and Cornus oﬃcinalis
(Zaopi). All of these natural drugs were provided by
the Department of Pharmacy, Xiangya Hospital, Central
South University. These drugs were mixed at a ratio of
10:10:3:10:10:10:10:10:10:6, and then boiled for 30
minutes three times in distilled water at a volume of 10-fold
the dry weight of the herb mixture. The solution was heated
until the drugs reached a concentration of 1.33g/mL (crude
drug/solution volume).
2.2. Experimental Animals and Treatment. A l la n i m a l su s e d
in this study were conventionally bred 6- to 8-week-old
male Sprague-Dawley rats (Experimental Animal Center of
Central South University, Changsha, China). This study was
carried out in strict accordance with the recommendations
from the Guide for the Care and Use of Laboratory Animals
published by the National Institutes of Health, USA. The
protocol was approved by the Ethics Committee at the
Asthma Research Institute, Hunan Province.
Twenty-four rats were divided into three groups using
a random digits table (n = 8 per group): control rats
(control),asthmaticrats(asthma),andasthmaticratstreated
with KTR (KTR). The rats were treated as follows: on day
0 and day 7, the asthma and KTR groups were sensitized
with an intraperitoneal injection of 100mg of ovalbumin
(OVA) (Sigma, USA), 200mg of aluminum hydroxide
(Sigma), and 6 × 109 heat-killed Bordetella pertussis (Wuhan
Institute of Biological Products, China) in 1mL of sterile
saline. The control rats were sham sensitized by using an
intraperitoneal injection of sterile saline without OVA. The
sensitized rats were exposed to 30 minutes of 1% OVA
(wt/vol) aerosol every day from day 14 to day 28, while the
control rats were exposed to aerosolized sterile saline only.
KTR-treated rats received a gastric gavage with the KTR
solution (10g/kg) 40 minutes prior to exposure. Control and
asthmaticratsreceivedagastricgavagewiththesamevolume
of distilled water into the stomach at 40 minutes before
exposure.
2.3. Measurement of Bronchial Responsiveness. In vivo airway
responsiveness to histamine was measured 24 hours after the
last OVA challenge using whole-body plethysmography (PLY
3211, Buxco Electronics). Rats were treated for 2 minutes
with aerosolized saline or increasing doses of histamine
generated by an ultrasonic nebulizer, and airway resistance
was measured. Histamine-induced bronchoconstriction was
calculated as the index of percent increase in airway resis-
tance as compared to the peak of the reaction with baseline
airway resistance [11, 13].
2.4. Tissue Preparation. After determination of bronchial
responsiveness, blood from each rat was obtained by cardiac
puncture, and the serum was inactivated by heating at
56◦C for 30 minutes, then ﬁltered through a 0.22μmﬁ l t e r
a n ds t o r e di n−20◦C until use. The left adrenal glands
were excised and ﬁxed in 4% paraformaldehyde or in 2%
glutaraldehyde stored at −80◦C until use. After pulmonary
artery perfusion, the right middle lung lobe from each rat
was also ﬁxed in 4% paraformaldehyde and stored at −80◦C.
2.5. Medium Preparation. Medium A was prepared as a
mixture of 85% DMEM serum-free medium (Gibco, USA)
and 15% serum from experimental rats. According to the
origin of serum, three Medium A subgroups were generated:
serum from control rats (control serum), serum from
asthmaticrats(asthmaserum),andserumfromKTR-treated
rats (KTR serum). Medium B was prepared as a mixture
of 15% fetal bovine serum (Gibco, USA) and 85% DMEM
serum-free medium.
2.6. Primary Culture of Rat AMCC [14, 15]. Adrenal glands
were obtained from conventionally bred 6- to 8-week-old
male Sprague-Dawley rats. Medullae were carefully freed
from the capsular and cortical tissue under sterile conditions
and incubated with Hanks’ balanced salt solution. Subse-
quently, medullae were dissociated with 0.1% type I col-
lagenase dissolved in glucose-enriched phosphate-buﬀered
saline for 40 minutes. After harvesting by centrifugation and
resuspending in culture medium B, the cells were adjusted to
a cell concentration of 5-6 × 106/mL and incubated at 37◦C.
Mediumwaschangedafter24hours,andthenevery48hours
thereafter, to remove dead cells and cell debris.
The cultures in medium B were maintained for a total of
5 days and divided into the three experimental groups for
treatment with one of the diﬀerent medium A subgroups
described above. Seventy-two hours after the AMCC cells
were treated with medium A (experimental serum), the cells
and the supernatants were collected for subsequent analysis.
2.7. Hematoxylin and Eosin (HE) Staining. The tissue of lung
and adrenal medulla were ﬁxed in 4% paraformaldehyde
a n dt h e ne m b e d d e di np a r a ﬃn. Tissue sections (4μm) were
stained with HE, and the morphological changes of lung and
adrenal medulla were observed under a light microscope.
The airway wall thickness was quantiﬁed by pathology image
analysis system.
2.8. Transmission Electron Microscopy. Adrenal medulla and
AMCCs were ﬁxed with 2% glutaraldehyde in 0.1M cacody-
late buﬀer, pH 7.2. Three hours later, specimens were
postﬁxed in buﬀered 1% OsO4 for 1 hour following by
hydrating in a decreasing ethanol series and embedding
in Epon-Araldite. Ultrathin sections (70nm) from the
diﬀerentspecimenswerestainedwithuranylacetateandlead
citrate and examined with an H-7500 transmission electron
microscope (Hitachi, Japan). Ultrastructural changes were
assessed by pathologists who were blinded with respect to
treatments.
2.9. Enzyme-Linked Immunosorbent Assay (ELISA). The lev-
els of EPI, corticosterone, and NGF in serum or cellu-
lar supernatant were quantiﬁed by commercially available
ELISA kit and antibodies, according to the protocol provided
by the supplier (R&D, USA). Immunoreactivity was deter-
mined by an ELISA reader at 450nm.Evidence-Based Complementary and Alternative Medicine 3
2.10. Reverse Transcription (RT) PCR. Total RNA was
extracted from tissues or cells using Trizol reagent (Invit-
rogen, USA) according to the manufacturer’s instructions.
For RT-PCR reactions, primer sequences were designed that
yielded 137 and 307bp products of peripherin and GAPDH,
respectively. The gene-speciﬁc primer sequences were as fol-
lows:5 -GGTGGAGGTAGAGGCAACA-3  (forward)and5 -
TCGGACAGGTCAGCGTATT-3  (reverse) for peripherin,
and 5 -TGAACGGGAAGCTCACTGG-3  (forward) and 5 -
TCCACCACCCTGTTGCTGTA-3  (reverse) for GAPDH.
The PCR ampliﬁcation program consisted of preheating at
94◦C for 5 minutes and 35 cycles of denaturing (94◦C,
30 seconds), annealing (60◦C, 30 seconds), and extension
(72◦C, 1 minute), followed by a ﬁnal extension at 72◦Cf o r
10 minutes. The PCR products were electrophoresed on a
2% agarose gel to conﬁrm size. Results were normalized to
GAPDH, which was used as an internal control.
2.11. Immunohistochemistry. After embedding in paraﬃn
at 4◦C overnight, the tissues were sectioned (4μm) and
mounted on slides. The tissue sections were then deparaf-
ﬁnized in toluene and rehydrated in a decreasing ethanol
series. Endogenous peroxidase activity was blocked with
3% H2O2 for 10 minutes. The sections were then incu-
bated with polyclonal rabbit antibodies against rat (anti-
phenylethanolamineN-methyltransferase(PNMT),1:2500;
antiperipherin, 1:150; both from Millipore, USA) at 4◦C
overnight and followed by incubation with biotin-labeled
goat anti-rabbit immunoglobulin (Ig)G (1:500; Zhongshan
Goldenbridge Biotechnology, China) for 20 minutes. The
sections were then treated with the streptavidin-peroxidase
kit (Zhongshan Goldenbridge Biotechnology, China) and
developed with DAB substrate. Counterstaining was per-
formed with hematoxylin. Afterwards, the sections were
incubatedwithnonimmunerabbitserafornegativecontrols.
The results were observed under a light microscope (100x)
and the average optical density was calculated by using
the Image Pro Plus 6.0 software (IPP6.0) for subsequent
statistical analysis.
2.12. Western Blot Analysis. Total proteins were extracted
by RIPA Lysis Buﬀer (Takara, Japan). Thirty micrograms
of protein were resolved by 10% sodium dodecyl sulfate-
polyacrylamide gel electrophoresis (SDS-PAGE). Proteins
were then electrotransferred to polyvinylidene ﬂuoride
(PVDF) membrane at 120V for 1.5 hours. Nonspeciﬁc
binding wasblocked by incubating with0.05g/mL skim milk
powder at room temperature (20◦C) for 2 hours, and then
membranes were incubated at 4◦C overnight with rabbit
anti-ratperipherinpolyclonalantibodies(1:1000;Millipore,
USA). After washing with PBST, the membranes were incu-
bated at 37◦C for 1 hour with secondary antibodies (1:5000;
Sigma) and visualized by using the enhanced chemilumines-
cence reagent system (Pierce, USA). Results were normalized
to GAPDH, which was used as an internal control.
2.13. Statistical Analysis. Data are presented as mean ±
standard deviation (x ± SD). One-way analysis of variance
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Figure 1: Changes in rat airway resistance in response to histamine
exposure. Rats in three groups were treated with aerosolized
saline or increasing doses of histamine generated by an ultrasonic
nebulizer. Airway resistance was measured by whole-body plethys-
mography and expressed as the index of percent increase in airway
resistanceascomparedtothepeakofthereactionwithbaseline.The
values are expressed means ± SD (n = 8). ∗indicates signiﬁcant
diﬀerence compared to the control group (P<0.05); indicates
signiﬁcant diﬀerence between KTR-treatment and asthma groups
(P<0.05).
was used for multiple comparisons, followed by Fisher’s
protected least signiﬁcant diﬀerence test. A P value of less
than 0.05 was considered statistically signiﬁcant.
3. Results
3.1. Airway Responsiveness to Histamine. Administration
of increasing concentrations of histamine caused gradual
increases in airway resistance in each group. When the
concentration of histamine reached 0.16mg/mL and above,
airwayresistanceintheasthmagroupwashigherthanthatin
the control group (P<0.05). KTR treatment attenuated the
airway resistance in asthmatic rats (P<0.05) (Figure 1).
3.2. Morphological Changes of Lung Tissue. Morphological
changes in lung tissue were evaluated by examining lesions
in asthmatic rats. We found that, compared with the control
rats, asthmatic rats had an increased shedding of epithelial
cells,remarkableinﬁltrationofeosinophils,andlymphocytes
surrounding the airway. These pathological changes were
found to be reduced in the KTR-treated rats. The results
showed that the airway wall thickness in asthmatic rats
(38.25 ± 4.98μm2/μm) was thicker than that in control rats
(18.88 ± 3.36μm2/μm) (P<0.05), and this eﬀect was
alleviated in KTR-treated rats (25.38 ± 5.42μm2/μm; versus
asthma, P<0.05) (Figure 2).
3.3. Alterations in the Adrenal Medulla. Compared with
the control rats, asthmatic rats presented with vacuolar
degeneration, tissue edema, and increased lipid in AMCC,4 Evidence-Based Complementary and Alternative Medicine
(a) (b) (c)
Figure 2: Pathological changes in rat lung tissue in response to induced asthma and KTR treatment. Representative micrographs (HE
staining, 100x) of lungs from control rats (a), asthmatic rats (b), and KTR-treated asthmatic rats (c).
(a) (b) (c)
(d) (e) (f)
Figure 3: The pathological changes of rat adrenal medulla in response to induced asthma and KTR treatment. Representative micrographs
(HE staining, 100x) of adrenal medulla in control rats (a), asthmatic rats (b), and KTR-treated asthmatic rats (c). Representative electron
micrographs (10000x) of adrenal medulla in control rats (d), asthmatic rats (e), and KTR-treated asthmatic rats (f). The arrows show
vacuolar degeneration (black arrow), chromaﬃn granules (red arrow), swollen cytoplasm, and mitochondria (blue and white arrows),
respectively.
as observed under light microscope. However, these lesions
were reversed by KTR treatment (Figures 3(a)–3(c)).
Electron microscopy revealed a regular morphology of
AMCC in control rats, which contained a clear structure
of mitochondria and abundant chromaﬃn granules. Lesions
were evident in asthmatic rats, including swollen cytoplasm
and mitochondria, and decreased chromaﬃn granules.
These pathological changes were relieved in the KTR-treated
rats (Figures 3(d)–3(f)).
3.4. Changes in EPI, Corticosterone, and NGF Levels. EPI
levels in asthmatic rats were lower than in control rats
(P<0.05),asevidencedbyELISA.Comparedwithasthmatic
rats, the EPI levels increased signiﬁcantly in KTR-treated rats
(P<0.05)(Figure 4(a)).Corticosteronelevelswereincreased
in asthmatic rats, as compared to that in control rats (P<
0.05), and corticosterone levels were further increased in
asthmatic rats treated with KTR (P<0.05) (Figure 4(b)).
NGFlevelswerealsoincreasedinasthmaticrats,ascompared
t oc o n t r o lr a t s( P<0.05), but this response was attenuated
in asthmatic rats by KTR treatment (P<0.05) (Figure 4(c)).
3.5. Changes in PNMT and Peripherin Protein Expressions
in Adrenal Medulla. Under normal physiologic conditions,Evidence-Based Complementary and Alternative Medicine 5
0
2
4
6
8
10
12
E
P
I
 
(
n
g
/
m
L
) ∗
Control rat Asthma rat KTR rat
(a)
∗
0
100
200
300
400
500
600
C
o
r
t
i
c
o
s
t
e
r
o
n
e
 
(
p
g
/
m
L
)
Control rat Asthma rat KTR rat
(b)
∗
0
20
40
60
80
100
120
N
G
F
 
(
p
g
/
m
L
)
Control rat Asthma rat KTR rat
(c)
∗
Control cell Asthma cell KTR cell
0
5
10
15
20
25
30
E
P
I
 
(
n
g
/
m
L
)
(d)
Figure 4: Changes in levels of EPI, corticosterone, and NGF in rats in response to induced asthma and KTR treatment. The levels of EPI,
corticosterone, and NGF in rats (in vivo: (a), (b), and (c), resp.) and the level of EPI in cultured AMCC supernatant (in vitro: (d)) were
detected by ELISA. The values are presented as mean ± SD (in vivo: n = 8, in vitro: n = 3). ∗indicates signiﬁcant diﬀerence compared to the
control group (P<0.05); indicates signiﬁcant diﬀerence between KTR-treatment and asthma groups (P<0.05).
PNMT is primarily expressed in chromaﬃn cells and absent
in neurons. We found that the immunostaining of PNMT
was distributed throughout cytoplasm. In control rats,
the density of immunostaining was remarkably high in
the adrenal medulla. Compared with the control rats, the
expression of PNMT in asthmatic rats was decreased (P<
0.05), while a further enhanced expression was found in
asthmatic rats treated with KTR (P<0.05) (Figures 5(a)–
5(d)).
Peripherin is rarely expressed in chromaﬃn cells and
has high expression in neurons. We found that peripherin
immunostaining was mainly localized in the cytoplasm.
Compared with control rats, the density of immunostaining
in asthmatic rats was higher than that in control rats (P<
0.05). However, KTR treatment inhibited the expression of
peripherin in asthmatic rats (P<0.05) (Figures 5(e)–5(h)).
3.6. Changes in Peripherin Gene and Protein Expressions in
the Adrenal Medulla. Compared with control rats, asthmatic
rats had signiﬁcantly increased amounts of peripherin
mRNA and protein expression (P<0.05), as evidenced by
RT-PCR and western blot, respectively. Compared with the
asthmaticrats,peripherinmRNAandproteinexpressionwas
inhibited by KTR treatment (P<0.05) (Figures 6(a) and
6(b)).
3.7. AMCC Structural Alterations In Vitro . Electron mi-
croscopy indicated that cultured chromaﬃn cells treated
with control serum in vitro were of regular shape and
contained abundant chromaﬃn granules. A decrease in the
amount of chromaﬃn granules and neurite-like processes
and in swollen cytoplasm and mitochondria appeared in
cells upon treatment with asthmatic serum, as compared
withcontrolcells.Thesepathologicalchangeswerealleviated
with treatment with KTR serum, and there were numerous
lysosomes present in the cytoplasm (Figure 7).
3.8. EPI Levels in Supernatants of Cultured AMCC. Com-
pared with cells treated with control serum, EPI levels were
sharply decreased in the supernatant of cells treated with
asthmatic serum (P<0.05), asevidenced byELISA. This was
reversed by KTR serum treatment (P<0.05) (Figure 4(d)).
3.9. Peripherin Gene and Protein Expressions in Cultured
AMCC. Compared with the control cells, AMCC treated
with asthmatic serum showed a signiﬁcant increase in
peripherin mRNA and protein expressions (P<0.05), as
evidenced by RT-PCR and western blot, respectively. This
increase was inhibited by KTR serum (P<0.05) (Figures
6(c) and 6(d)).
4. Discussion
Kidney-tonifying drugs are often used to treat asthma in
TCM. Previous reports have suggested that the eﬀects of
these drugs are mediated by their ability to upregulate6 Evidence-Based Complementary and Alternative Medicine
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Figure 5:ChangesinPNMTandperipherinproteinexpressioninadrenalmedullaofratsinresponsetoinducedasthmaandKTRtreatment.
The expressions of PNMT and peripherin in the adrenal medulla of rats were detected by immunohistochemistry. Representative images
of immunostaining (DAB, 100x) for PNMT are presented for control rats (a), asthmatic rats (b), and KTR-treated asthmatic rats (c).
Representative images of immunostaining (DAB, 100x) for peripherin are presented for control rats (e), asthmatic rats (f), and KTR-treated
asthmatic rats (g). Bar graphs on the right panels represent the average optical density of PNMT (d) and peripherin (h). The values are
presentedasmeans ±SD(n = 8). ∗indicatessigniﬁcantdiﬀerencecomparedtothecontrolgroup(P<0.05); indicatessigniﬁcantdiﬀerence
between KTR-treatment and asthma groups (P<0.05).
plasma cortisol production by stimulating the adrenal cortex
[3]. The KTR formula contained Rehmannia Glutinosa and
medicinal Indian mulberry root, which have each been
shown to improve adrenal cortex function and to increase
glucocorticoid receptor expression, thereby relieving asthma
[16]. Furthermore, monkshood could act as a β2-adrenergic
receptor agonist, which can relieve bronchoconstriction in
asthma [17]. As well as glucocorticoids, EPI and the other
β2-adrenergic receptor agonists play an important role in
treating asthma. However, it is not known whether kidney-
tonifyingdrugsaﬀectthesecretionofEPI.Asthmaticpatients
have been clinically shown to have decreased levels of
endogenousEPI,whichmaybetheimportantreasonforsup-
plementing exogenous EPI in relieving asthma [8, 9]. In the
present study, EPI concentrations were found to be reduced
in asthmatic rats, and KTR administration attenuated this
decrease. Furthermore, EPI levels were further found to be
correlated with the degree of bronchial hyperreactivity and
lung lesions in asthmatic rats. These results indicated that
the mechanism underlying KTR eﬀects in treating asthma is
mediated by regulating EPI concentration.
EPI is a β2-adrenergic receptor agonist that is mainly
secreted from the adrenal medulla [6, 7]. The adrenal gland
consists of cortex and medulla, the latter of which is an
endocrine organ that originates from the neuroectoderm.
During early embryonic periods, the development of adrenal
medulla is parallel with that of the sympathetic nerves. In
later stages the adrenal medulla invades the adrenocortical
rudimentum, at which time the adrenal medulla gains
its characteristic endocrine secretion properties [18]. The
homology between the adrenal medulla and sympathetic
nerves underlies the ability of AMCC to transform to
sympathetic neurons, and this is induced by the activities of
nerve growth factor (NGF) [18–20]. It is well known that
sympathetic neurons synthesize and secrete noradrenaline
and dopamine, but not adrenaline. As a result, the transition
to neurons inhibits the secretion of EPI in AMCC.
NGF is the most important neurotrophic factor involved
in neuronal growth, survival, and diﬀerentiation. NGF
expression and activity is enhanced in asthma [21], and
NGF levels are consistent with the degree of bronchial
hyperreactivity [22]. In our previous studies, we observed
a trend toward transformation from the AMCC phenotype
to that of neurons in asthmatic rats. This was accompanied
by a decrease in EPI and elevation in NGF, and anti-NGF
inhibited this transformation. These data indicated that the
decrease in EPI results from a phenotype transformation
of AMCC to neuron, which is promoted by elevated NGF
in asthma [10–12, 23]. In the present study, decreased EPI
and elevated NGF were also found in asthmatic rats, and
there was a decrease in the density of chromaﬃn granules,
and swollen cytoplasm and mitochondria also appeared in
AMCCofasthmaticrats.KTRtreatmentincreasedEPIlevels,
decreased NGF levels, and alleviated the ultrastructural
lesions in AMCC.
During the development and regeneration of nerve
cells, peripherin (a type III intermediate ﬁlament) plays
an important role in cellular architecture through regulat-
ing axon formation, thus giving nerve cells their unique
morphology [24]. The importance of peripherin in this
development has been highlighted by a research study that
observed that depletion by peripherin-siRNA inhibited theEvidence-Based Complementary and Alternative Medicine 7
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Figure 6: Changes in peripherin gene and proteins expressions in rat adrenal medulla tissue and AMCC in response to induced asthma and
KTR treatment. Total RNA and cellular protein were isolated from adrenal medulla tissue in rats (in vivo: (a) and (b)) and AMCC (in vitro:
(c) and (d)), and the expressions of peripherin (mRNA and protein) in each group were detected by RT-PCR and western blot. Results were
normalized to GAPDH, which was used as an internal control, and the bar graphs on the right show the relative densitometry results. The
values are expressed means ± SD (in vivo: n = 8, in vitro: n = 3). GAPDH was used as an internal control. ∗indicates signiﬁcant diﬀerence
compared to the control group (P<0.05); indicates signiﬁcant diﬀerence between KTR-treatment and asthma groups (P<0.05).
(a) (b) (c)
Figure 7: Pathological changes of AMCC in vitro. Representative electron micrographs (20000x) of AMCC treated with control serum (a),
asthma serum (b), and KTR serum (c). The arrows show chromaﬃn granules (blue arrow), neurite-like process (red arrow), and lysosome
(green arrow), respectively.8 Evidence-Based Complementary and Alternative Medicine
initiation, extension, and maintenance of neuritis [24]. Only
a subpopulation of AMCC are reactive to peripherin and
this is supported by the fact that AMCC expressing high
peripherin levels have a distinct shape that is similar to
that of nerve cells [25]. AMCC have also been implicated
in active downregulation of intermediate ﬁlament proteins
during embryonic development [18]. However, Nie found
thattheexpressionofperipherinwasincreasedintheadrenal
medulla of asthmatic rats, and in this process decreased
chromaﬃn granules and neurite-like processes appeared
in AMCC of asthmatic rats [23]. These data suggested
that increased peripherin expression may be a hallmark
of AMCC transformation in asthma. In the present study,
enhanced expression of peripherin was observed in the
adrenal medulla of asthmatic rats, which was normalized by
KTR treatment. The results suggest that the beneﬁcial eﬀects
of KTR in treating asthma are mediated by downregulation
of peripherin expression in AMCCs, thus inhibiting the
transformation of AMCCs to neurons.
PNMT, the rate-limiting enzyme that catalyzes nor-EPI
to EPI, is mainly expressed in adrenergic chromaﬃn cells,
rather than in nerve cells. Decreases in PNMT mediate the
transition from AMCCs to neurons. Glucocorticoids are
known to promote the expression of PNMT in the adrenal
medulla [26–28]. In our recent study, we found that the
PNMT expression was reduced in the adrenal medulla of
asthmaticrats,andNGFadministrationintensiﬁedthiseﬀect
[10]. High concentrations of glucocorticoids in the adrenal
medulla have been shown to prevent ﬁber outgrowth from
medullary chromaﬃnc e l l sin vivo and inhibit the transfor-
mation of AMCC into neurons [15, 29, 30]. These results
further support the importance of NGF and glucocorticoids
in AMCC fate [15, 31].
In the current study, PNMT expression was found to
be decreased in asthmatic rats, consistent with decreased
EPI and increased NGF levels, and KTR treatment inhibited
these changes. Despite increased corticosterone levels in
asthmatic rats, there remained a trend for NGF-induced
transformation of AMCC. The further increase in corti-
costerone in asthmatic rats treated by KTR may act as a
compensatory mechanism, as supplementation with exoge-
nousglucocorticoidsisahighlyeﬀectivetreatmentinasthma
patients. To some extent, these data suggest that the eﬀect
of KTR in treating asthma is dependent on maintaining the
phenotype of AMCC, which may be ascribed to correcting
the imbalance of NGF and glucocorticoids; as a result, EPI
concentrations would be expected to be increased, thus
relieving bronchospasms.
To test this hypothesis, we cultured AMCC in vitro and
treated them with sera from control, asthmatic, or KTR-
treated rats. The results demonstrated that treatment with
sera from asthmatic rats caused a decrease in the density
of chromaﬃn granules and development of a synapse-like
cellular structure. In addition, asthmatic sera also caused a
concurrent decrease in EPI and increase in peripherin. These
changes were attenuated in AMCCs treated with the sera
from KTR-treated rats.
In summary, it can be concluded that administration
of KTR to asthmatic rats leads to upregulation of EPI
and prevention of AMCC transformation to neurons, thus
allowing for normal endocrine function.
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